IP Library Granted Patent US 9,403,903
Granted Patent B2
US 9,403,903 · App. 14/706,484 · Granted Aug 2, 2016

Acceptor framework for CDR grafting

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,403,903
App. No.
14/706,484
Granted
Aug 2, 2016
Kind
B2
Abstract

The present invention relates to an antibody acceptor framework and to methods for grafting non-human antibodies, e.g., rabbit antibodies, using a particularly well suited antibody acceptor framework. Antibodies generated by the methods of the invention are useful in a variety of diagnostic and therapeutic applications.

Claims (8)

1. An isolated nucleic acid encoding a human heavy chain acceptor framework comprising SEQ ID NO: 1, wherein the human heavy chain acceptor framework comprises an amino acid substitution at position 12, 103, and/or 144 (Aho numbering).

2. The isolated nucleic acid of claim 1 , wherein the substitution is

(a) Serine (S) at position 12;

(b) Serine (S) or Threonine (T) at position 103; and/or

(c) Serine (S) or Threonine (T) at position 144.

3. An isolated nucleic acid encoding a human heavy chain acceptor framework comprising SEQ ID NO: 1.

4. A vector comprising the nucleic acid of claim 3 .

5. A host cell comprising the vector of claim 4 .

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2022
From: CELL MEDICA INC.
To: CELL MEDICA, INC.
Reel/Frame 060529/0195 →
CHANGE OF NAME Recorded Jul 18, 2022
From: ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC
To: ESBATECH, A NOVARTIS COMPANY LLC
Reel/Frame 060529/0545 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2021
From: CELL MEDICA SWITZERLAND AG
To: CELL MEDICA INC.
Reel/Frame 054988/0114 →